Argentina tackles hidden hypertension under-monitoring:
This article was originally published in Clinica
More than 15,000 pharmacies across Argentina are to provide a free blood pressure monitoring service, as part of a national awareness campaign. Around 10 million people in Argentina have high blood pressure, yet around a half are not aware of their condition, according to the national pharmaceutical confederation (COFA), which is co-ordinating the initiative through its member pharmacists. COFA is to publish the results of the programme, which was due to be launched on October 12, to mark national blood pressure monitoring day. Hypertension is the main risk factor in the development of cardiovascular disease (which is the leading cause of death in Argentina) and affects one in four adults and around a half of all people aged over 60, says COFA.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.